Cargando…
TRPM4 and TRPV2 are two novel prognostic biomarkers and promising targeted therapy in UVM
Uveal melanoma (UVM) is the most common primary intraocular malignancy tumor in adults. Almost 50% of UVM patients develop metastatic disease, and is usually fatal within 1 year. However, the mechanism of etiology remains unclear. The lack of prognostic, diagnostic and therapeutic biomarkers is a ma...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445434/ https://www.ncbi.nlm.nih.gov/pubmed/36081847 http://dx.doi.org/10.3389/fmolb.2022.985434 |